Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis-Reference-Cited by-同舟云学术

Incidence and risk factors for pacemaker implantation in light‐chain and transthyretin cardiac amyloidosis

Published:2022-05-16 Issue:7 Volume:24 Page:1227-1236
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Porcari Aldostefano¹^ORCID,Rossi Maddalena¹,Cappelli Francesco²³,Canepa Marco⁴,Musumeci Beatrice⁵,Cipriani Alberto⁶,Tini Giacomo⁵,Barbati Giulia⁷,Varrà Guerino Giuseppe¹,Morelli Cristina³,Fumagalli Carlo³,Zampieri Mattia³,Argirò Alessia³,Vianello Pier Filippo⁴,Sessarego Eugenio⁴,Russo Domitilla⁵,Sinigiani Giulio⁶,De Michieli Laura⁶,Di Bella Gianluca⁸,Autore Camillo⁵,Perfetto Federico³,Rapezzi Claudio⁹¹⁰,Sinagra Gianfranco¹,Merlo Marco¹

Affiliation:

1. Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department Azienda Sanitaria Universitaria Giuliano‐Isontina (ASUGI), University of Trieste Trieste Italy

2. Tuscan Regional Amyloidosis Centre Careggi University Hospital Florence Italy

3. Cardiomyopathy Unit Careggi University Hospital, University of Florence Florence Italy

4. Cardiovascular Unit, Department of Internal Medicine University of Genova, Ospedale Policlinico San Martino IRCCS Genoa Italy

5. Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology Sapienza University Rome Italy

6. Department of Cardiac, Thoracic and Vascular Sciences and Public Health University of Padua Padua Italy

7. Biostatistics Unit, Department of Medical Sciences University of Trieste Trieste Italy

8. Department of Cardiology University of Messina Messina Italy

9. Cardiothoracic Department University of Ferrara Ferrara Italy

10. Maria Cecilia Hospital GVM Care & Research Ravenna Italy

Funder

European Society of Cardiology

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2533

Reference26 articles.

1. Epidemiology of Cardiac Amyloidosis–Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States

2. Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery

3. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization—the first insight from the AC-TIVE Study

4. Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey

5. Electrophysiological Manifestations of Cardiac Amyloidosis

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of cardiac conduction disease in patients with cardiac amyloidosis: A national retrospective cohort study;International Journal of Cardiology;2024-12

2. Changes of clinical characteristics, distribution of red flags and prognosis in contemporary patients with wild-type transthyretin amyloidosis cardiomyopathy;Annals of Medicine;2024-09-09

3. Arrhythmic Risk Stratification—General Considerations in Specific Scenarios;Journal of Cardiovascular Development and Disease;2024-09-07

4. Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty;ESC Heart Failure;2024-08-21

5. Actualización en amiloidosis cardiaca por transtiretina wild-type: guía clínica para su diagnóstico y tratamiento;Medicina Clínica;2024-08